Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALK | Q9UM73 | 11/20 | 0.76 |
| ▸ | INSR | P06213 | 9/20 | 0.76 |
| ▸ | IGF1R | P08069 | 8/20 | 0.76 |
| ▸ | PTK2 | Q05397 | 3/20 | 0.76 |
| ▸ | MAPK8 | P45983 | 2/20 | 0.76 |
| ▸ | MAPK9 | P45984 | 2/20 | 0.76 |
| ▸ | MAPK10 | P53779 | 2/20 | 0.76 |
| ▸ | EGFR | P00533 | 2/20 | 0.76 |
| ▸ | LRRK2 | Q5S007 | 2/20 | 0.76 |
| ▸ | FGFR1 | P11362 | 2/20 | 0.76 |
| ▸ | CDC7 | O00311 | 1/20 | 0.76 |
| ▸ | PLK4 | O00444 | 1/20 | 0.76 |
| ▸ | CHEK1 | O14757 | 1/20 | 0.76 |
| ▸ | AURKA | O14965 | 1/20 | 0.76 |
| ▸ | DCLK1 | O15075 | 1/20 | 0.76 |
| ▸ | PDPK1 | O15530 | 1/20 | 0.76 |
| ▸ | DAPK3 | O43293 | 1/20 | 0.76 |
| ▸ | DYRK3 | O43781 | 1/20 | 0.76 |
| ▸ | JAK2 | O60674 | 1/20 | 0.76 |
| ▸ | PRKD3 | O94806 | 1/20 | 0.76 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4088683 | 0.96 | ALK (0.70) | ALKINSRIGF1RPTK2MAPK8 | |
| SCHEMBL4089439 | 0.90 | ALK (0.81) | ALKINSRIGF1RPTK2MAPK8 | |
| SCHEMBL1061877 | 0.88 | ALK (0.72) | ALKINSRIGF1RPTK2MAPK8 | |
| SCHEMBL4103904 | 0.87 | ALK (0.75) | ALKINSRIGF1RPTK2MAPK8 | |
| SCHEMBL4099216 | 0.86 | ALK (0.75) | ALKINSRIGF1RPTK2MAPK8 | |
| SCHEMBL4099222 | 0.86 | ALK (0.75) | ALKINSRIGF1RPTK2MAPK8 | |
| SCHEMBL375524 | 0.86 | PTK2 (1.00) | ALKINSRIGF1RPTK2MAPK8 | |
| SCHEMBL29378728 | 0.86 | PTK2 (1.00) | ALKINSRIGF1RPTK2MAPK8 | |
| SCHEMBL29730430 | 0.86 | PTK2 (1.00) | ALKINSRIGF1RPTK2MAPK8 | |
| SCHEMBL13849411 | 0.86 | INSR (0.56) | ALKINSRIGF1RPTK2MAPK8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090131436-A1 | Pyrimidine Derivatives | NOVARTIS AG (CH) | 2009-05-21 | — | — | US | claimed |
| US-20090131436-A1 | Pyrimidine Derivatives | NOVARTIS AG (CH) | 2009-05-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090131436-A1 | Pyrimidine Derivatives | DPYD, TYMP, TYMS | ALK 2060/4885INSR 2047/4885IGF1R 4608/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.